REQUEST A DEMO
Total
USD $0.00
Search more companies

Anya Biopharm Inc. (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Anya Biopharm Inc. Profile Updated: February 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Anya Biopharm Inc. is based in Taiwan, China. The head office is in Taipei City. The enterprise currently operates in the Research and Development in Nanotechnology sector. It was incorporated on April 01, 2026. From the latest financial highlights, Anya Biopharm Inc. reported a net sales revenue increase of 462.57% in Q2C2025. There was a total negative growth of 18.17% in Anya Biopharm Inc.’s total assets over the same period. The enterprise’s net profit margin increased by 2563.86% in 2025.

Headquarters
4F., No. 3-2, Yuanqu St., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Anya Biopharm Inc. report to view the information.

Website: http://www.anyabiopharm.com.tw

Basic Information
Outstanding Shares:
Purchase the Anya Biopharm Inc. report to view the information.
Financial Auditors:
Purchase the Anya Biopharm Inc. report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
13.28%
Purchase this report to view the information.
11.16%
Purchase this report to view the information.
4.77%
Purchase this report to view the information.
4.77%
Purchase this report to view the information.
4.4%
Subsidiaries
Anya Biopharm India Llp (India)
99%
Company Performance
Financial values in the chart are available after Anya Biopharm Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
462.57%
Total Operating Revenue
460.17%
Operating Profit
0.02%
EBITDA
0.84%
Net Profit/Loss for the Period
-127%
Total Assets
-18.17%
Total Equity
-15.86%
Operating Profit Margin
3406.8%
Net Profit Margin
2563.86%
Return on Equity (ROE)
-10.79%
Debt / Equity
-102%
Quick Ratio
20193.81%
Cash Ratio
5.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?